Clinical Trial Update: Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating regulatory T cell therapy in liver transplant patients with end-stage liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: End-stage Liver Disease | Phase 1, Phase 2 | Status: COMPLETED